Stockscreener 앱 받기
60.13
2.00%
-1.23
시간 외 거래:
60.13
전일 마감가:
$61.36
열려 있는:
$61.41
하루 거래량:
2.88M
Relative Volume:
1.18
시가총액:
$7.50B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-14.18
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
-10.81%
1개월 성능:
+30.24%
6개월 성능:
+40.95%
1년 성능:
+147.14%
1일 변동 폭
$58.67
$61.95
1주일 범위
$57.50
$68.00
52주 변동 폭
$20.14
$68.00
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
60.13 | 7.65B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
492.60 | 184.84B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.21 | 142.52B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
642.99 | 51.24B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.75 | 36.42B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.68 | 31.29B | 15.70B | 1.24B | 2.01B | 6.91 |
가든트헬스 Stock (GH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-24 | 재개 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Guggenheim | Neutral |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 개시 | Craig Hallum | Buy |
| 2022-10-06 | 개시 | Stephens | Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-06-03 | 개시 | Piper Sandler | Overweight |
| 2022-04-28 | 재개 | BTIG Research | Buy |
| 2022-02-24 | 재확인 | Canaccord Genuity | Buy |
| 2022-02-24 | 재확인 | Citigroup | Buy |
| 2022-02-24 | 재확인 | Cowen | Outperform |
| 2022-02-24 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-24 | 재확인 | SVB Leerink | Outperform |
| 2022-02-24 | 재확인 | Stifel | Buy |
| 2022-02-24 | 재확인 | Wells Fargo | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-11 | 개시 | Stifel | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-06-12 | 개시 | BTIG Research | Buy |
| 2020-02-21 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-08-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-04-16 | 개시 | Canaccord Genuity | Buy |
| 2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 재확인 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | BofA/Merrill | Neutral |
| 2018-10-29 | 개시 | JP Morgan | Overweight |
| 2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
New Blood Test Algorithm Shows Sensitivity, Specificity in CRC Screening - CancerNetwork
Live market analysis of Guardant Health Inc.July 2025 Opening Moves & Weekly High Return Stock Forecasts - Newser
Is Guardant Health Inc. a turnaround storyEarnings Recap Summary & Weekly Watchlist for Hot Stocks - خودرو بانک
Growth Review: How does Guardant Health Inc. score in quality rankingsJuly 2025 PreEarnings & Fast Gain Stock Trading Tips - خودرو بانک
What to expect from Guardant Health Inc. in the next 30 daysMarket Performance Report & Community Shared Stock Ideas - Newser
Is Guardant Health Inc. showing signs of accumulationBull Run & Free Weekly Watchlist of Top Performers - Newser
Guardant Health reports positive clinical readout update for Shield algorithm - Yahoo Finance
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test - biospace.com
Signal strength of Guardant Health Inc. stock in tech scannersJuly 2025 Patterns & Smart Swing Trading Techniques - Newser
Detecting price anomalies in Guardant Health Inc. with AIOptions Play & Real-Time Volume Spike Alerts - Newser
Multi asset correlation models including Guardant Health Inc.2025 Support & Resistance & Safe Swing Trade Setups - Newser
Volume spikes in Guardant Health Inc. stock – what they meanJuly 2025 Sentiment & Community Trade Idea Sharing - Newser
Guardant Health Surges to $280M in Volume as Stock Plunges 5.69% to 378th Rank - AInvest
The Oncology Institute, Inc. shares rise 1.70% intraday after Guardant Health's positive clinical readout update for its Shield™ blood test. - AInvest
Guardant Health shares drop 9% after data release for Shield colorectal cancer screening test. - AInvest
Guardant Health Stock Falls on Colorectal Cancer Test UpdateNews and Statistics - IndexBox
Why Guardant Health (GH) Shares Are Plunging Today - Yahoo Finance
Guardant Health: BTIG Maintains Buy, Raises PT to $70 from $65 - AInvest
Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run - inkl
Guardant Health stock falls 8% despite Evercore ISI’s positive outlook - Investing.com
Guardant Health Updates Results for Shield Blood Test in Colorectal Cancer - MarketScreener
Guardant Health Plunges 11.05% Amid Insider Trading Concerns - AInvest
Guardant drops after trial data for cancer test (GH:NASDAQ) - Seeking Alpha
What drives Guardant Health Inc.’s stock priceJuly 2025 Rallies & Risk Controlled Swing Alerts - خودرو بانک
Guardant Health’s Shield blood test shows 84% sensitivity for colorectal cancer - Investing.com
Guardant Health Updates Shield Blood-Based Colorectal Cancer Screening Test with New Algorithm - AInvest
Liquid Biopsy Market to Hit USD 24.70 Billion by 2033 | Key Players - openPR.com
When is the best time to exit Guardant Health Inc.Earnings Overview Report & Daily Technical Stock Forecast Reports - Newser
How to read the order book for Guardant Health Inc.July 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
What to do if you’re stuck in Guardant Health Inc.Insider Buying & Fast Gain Stock Trading Tips - Newser
How volatile is Guardant Health Inc. stockPortfolio Risk Summary & Low Risk Investment Opportunities - خودرو بانک
Technical signs of recovery in Guardant Health Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Is it too late to sell Guardant Health Inc.IPO Watch & Advanced Swing Trade Entry Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares - Investing.com
Using flow based indicators on Guardant Health Inc.2025 Investor Takeaways & Long-Term Safe Investment Plans - Newser
Joyce, Guardant Health director, sells $6,584 in shares By Investing.com - Investing.com UK
Guardant Health Director Sells 100 Shares at $65.84 on 2025-09-02 - AInvest
Liquid Biopsy in Cancer Diagnostics Market to Witness Robust ~17% CAGR Expansion by 2032 | DelveInsight - Barchart.com
Is Guardant Health Inc. stock ready for a breakoutPortfolio Performance Summary & Stepwise Trade Execution Plans - Newser
Analyzing recovery setups for Guardant Health Inc. investors2025 Top Gainers & Risk Managed Trade Strategies - Newser
How to recover losses in Guardant Health Inc. stockPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Guardant Health Inc. stock daily chart insightsPortfolio Profit Report & Safe Capital Growth Tips - Newser
Is It Too Late to Sell Guardant Health Inc.2025 Big Picture & Daily Technical Forecast Reports - beatles.ru
Automated trading signals detected on Guardant Health Inc.Weekly Gains Report & Capital Efficiency Focused Strategies - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - Eastern Progress
Will Guardant Health Inc. stock split in the near futureMarket Weekly Review & Weekly Momentum Picks - Newser
Is GH's Q1 2025 forecast achievable? - AInvest
Advanced analytics toolkit walkthrough for Guardant Health Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Cyted Health’s $44M Series B: A Strategic Bet on Early Cancer Detection and Global Expansion - AInvest
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.21%
자본화:
|
볼륨(24시간):